Litigation Details for ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited (D. Del. 2020)
✉ Email this page to a colleague
ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited (D. Del. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-07-24 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 10,449,185 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-04-06 | 152 | Opinion - Memorandum Opinion | terms in U.S. Patent No. 10,449,185 ("the ' 185 patent"), U.S. Patent No. 10,646,480 …construction for multiple terms in U.S. Patent Nos. 10,449,185; 10,646,480; 10,849,891. Signed by Judge…the ' 480 patent"), and U.S. Patent No. 10,849,891 ("the ' 891 patent") ("…BACKGROUND The asserted patents share a common specification. These patents are directed to capsules…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
